Related Experiment Videos
Red cell deformability, splenic function and anaemia in thalassaemia
A M Dondorp1, K T Chotivanich, S Fucharoen
1Department of Internal Medicine and Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, Amsterdam, The Netherlands.
British Journal of Haematology
|May 8, 1999
Summary
Reduced red cell deformability (RCD) significantly contributes to anemia in thalassemia patients, especially after splenectomy. The spleen plays a key role in removing rigid red blood cells, impacting RCD and anemia severity.
Area of Science:
- Hematology
- Red Blood Cell Physiology
Background:
- Thalassemia is a group of inherited blood disorders characterized by reduced hemoglobin production.
- Anemia in thalassemia is complex, influenced by factors including red blood cell abnormalities.
Purpose of the Study:
- To investigate the relationship between red cell deformability (RCD) and anemia severity in alpha- and beta-thalassemia patients.
- To explore the role of the spleen in regulating RCD and its impact on anemia.
Main Methods:
- Measurement of red cell deformability (RCD) using an elongation index at high shear stress (30 Pa).
- Comparison of RCD in splenectomized versus non-splenectomized patients with alpha- and beta-thalassemia.
- Correlation analysis between RCD and the degree of anemia.
Main Results:
- Splenectomized patients exhibited significantly reduced RCD (very rigid erythrocytes) compared to those with intact spleens.
- A strong correlation was observed between reduced RCD and the degree of anemia in beta-thalassemia patients, irrespective of splenectomy status.
- These findings suggest a splenic recognition threshold for the removal of rigid red cells.
Conclusions:
- Reduced red cell deformability is a major determinant of anemia in thalassemia.
- The spleen plays a critical role in removing rigid erythrocytes, influencing anemia severity.
- RCD measurements can provide insights into the pathophysiology of anemia in thalassemia.